Acute estradiol and progesterone therapy in hospitalised adults to reduce COVID-19 severity: a randomised control trial

INTRODUCTION: As of November 2021, COVID-19 has killed more than 5 million people globally, including over 750 000 in the USA. Apart from corticosteroids, most available therapeutic options are at best marginally efficient in reducing disease severity and are extremely expensive. The systematic inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovre, Dragana, Bateman, Kristin, Sherman, Mya, Fonseca, Vivian A, Lefante, John, Mauvais-Jarvis, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635865/
https://www.ncbi.nlm.nih.gov/pubmed/34848523
http://dx.doi.org/10.1136/bmjopen-2021-053684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635865/
https://www.ncbi.nlm.nih.gov/pubmed/34848523
http://dx.doi.org/10.1136/bmjopen-2021-053684

Ejemplares similares